Category: Health & Pharmaceuticals

By Caspian Strydom / Aug, 17 2024

US FDA Bans Ajanta Pharma's Kamagra Tablets Over Manufacturing Violations and Health Risks

The US FDA has enforced an import ban on Ajanta Pharma's Kamagra tablets, citing manufacturing violations and health risks. Following multiple inspections, the company has been placed on the FDA's Red List, meaning all shipments will be detained without examination. Ajanta Pharma must address deficiencies and prove corrective actions to be removed from the list.

By Caspian Strydom / Mar, 22 2024

GlaxoSmithKline and Ranbaxy Reach Settlement on Valacyclovir U.S. Patent Litigation: Impacts and Insights

GlaxoSmithKline and Ranbaxy have reached an agreement to settle the U.S. patent litigation concerning valacyclovir. This move not only concludes years of legal disputes but also highlights the complexities surrounding patent laws in the pharmaceutical sector. The settlement could have wider implications for generic drug availability and healthcare costs.